390 related articles for article (PubMed ID: 28965628)
1. Cyclin D1 is significantly associated with stage of tumor and predicts poor survival in endometrial carcinoma patients.
Khabaz MN; Abdelrahman AS; Butt NS; Al-Maghrabi B; Al-Maghrabi J
Ann Diagn Pathol; 2017 Oct; 30():47-51. PubMed ID: 28965628
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical expression of galectin-3 is significantly associated with grade, stage and differentiation of endometrial carcinomas.
Al-Maghrabi J; Abdelrahman AS; Ghabrah T; Butt NS; Al-Maghrabi B; Khabaz MN
Pathol Res Pract; 2017 Apr; 213(4):348-352. PubMed ID: 28215640
[TBL] [Abstract][Full Text] [Related]
3. Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma?
Alvarez T; Miller E; Duska L; Oliva E
Am J Surg Pathol; 2012 May; 36(5):753-61. PubMed ID: 22498825
[TBL] [Abstract][Full Text] [Related]
4. Patterns of episialin/MUC1 expression in endometrial carcinomas and prognostic relevance.
Sivridis E; Giatromanolaki A; Koukourakis MI; Georgiou L; Anastasiadis P
Histopathology; 2002 Jan; 40(1):92-100. PubMed ID: 11903603
[TBL] [Abstract][Full Text] [Related]
5. Immunoexpression of Cyclin D1 and PTEN in Various Endometrial Pathologies.
Shawana S; Kehar SI; Masood S; Aamir I
J Coll Physicians Surg Pak; 2016 Apr; 26(4):277-82. PubMed ID: 27097697
[TBL] [Abstract][Full Text] [Related]
6. Clusterin immunoexpression is associated with early stage endometrial carcinomas.
Al-Maghrabi JA; Butt NS; Anfinan N; Sait K; Sait H; Bajouh O; Khabaz MN
Acta Histochem; 2016 May; 118(4):430-4. PubMed ID: 27079858
[TBL] [Abstract][Full Text] [Related]
7. Expression of the cell-cycle regulatory proteins (cyclins D1 and E) in endometrial carcinomas: correlations with hormone receptor status, proliferating indices, tumor suppressor gene products (p53, pRb), and clinicopathological parameters.
Mitselou A; Ioachim E; Zagorianakou N; Kitsiou E; Vougiouklakis T; Agnantis NJ
Eur J Gynaecol Oncol; 2004; 25(6):719-24. PubMed ID: 15597850
[TBL] [Abstract][Full Text] [Related]
8. Expression of cyclin D1 in normal, hyperplastic and neoplastic endometrium and its correlation with Ki-67 and clinicopathological variables.
Ozuysal S; Oztürk H; Bilgin T; Filiz G
Arch Gynecol Obstet; 2005 Feb; 271(2):123-6. PubMed ID: 14740230
[TBL] [Abstract][Full Text] [Related]
9. PAX2 and cyclin D1 expression in the distinction between cervical microglandular hyperplasia and endometrial microglandular-like carcinoma: a comparison with p16, vimentin, and Ki67.
Stewart CJ; Crook ML
Int J Gynecol Pathol; 2015 Jan; 34(1):90-100. PubMed ID: 25473758
[TBL] [Abstract][Full Text] [Related]
10. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
[TBL] [Abstract][Full Text] [Related]
11. FGFR2 alterations in endometrial carcinoma.
Gatius S; Velasco A; Azueta A; Santacana M; Pallares J; Valls J; Dolcet X; Prat J; Matias-Guiu X
Mod Pathol; 2011 Nov; 24(11):1500-10. PubMed ID: 21725289
[TBL] [Abstract][Full Text] [Related]
12. Cyclin D1 expression in endometrioid-type endometrial adenocarcinoma is correlated with histological grade and proliferative activity, but not with prognosis.
Nishimura Y; Watanabe J; Jobo T; Kato N; Fujisawa T; Kamata Y; Kuramoto H
Anticancer Res; 2004; 24(4):2185-91. PubMed ID: 15330159
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic utility of hepatocyte nuclear factor 1-beta immunoreactivity in endometrial carcinomas: lack of specificity for endometrial clear cell carcinoma.
Fadare O; Liang SX
Appl Immunohistochem Mol Morphol; 2012 Dec; 20(6):580-7. PubMed ID: 22495362
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression of cyclins, cyclin-dependent kinases, tumor-suppressor gene products, Ki-67, and sex steroid receptors in endometrial carcinoma: positive staining for cyclin A as a poor prognostic indicator.
Shih HC; Shiozawa T; Kato K; Imai T; Miyamoto T; Uchikawa J; Nikaido T; Konishi I
Hum Pathol; 2003 May; 34(5):471-8. PubMed ID: 12792921
[TBL] [Abstract][Full Text] [Related]
15. PTEN immunohistochemical expression is suppressed in G1 endometrioid adenocarcinoma of the uterine corpus.
Kimura F; Watanabe J; Hata H; Fujisawa T; Kamata Y; Nishimura Y; Jobo T; Kuramoto H
J Cancer Res Clin Oncol; 2004 Mar; 130(3):161-8. PubMed ID: 14689303
[TBL] [Abstract][Full Text] [Related]
16. The extent of cyclin D1 expression in endometrial pathologies and relevance of cyclin D1 with the clinicopathological features of endometrioid endometrial carcinoma.
Yildirim HT; Nergiz D; Sadullahoglu C; Akgunduz Z; Yildirim S; Dogan S; Sezer C
Indian J Pathol Microbiol; 2020; 63(3):412-417. PubMed ID: 32769330
[TBL] [Abstract][Full Text] [Related]
17. Coabnormal expression of cyclin D1 and p53 protein in human uterine endometrial carcinomas.
Nikaido T; Li SF; Shiozawa T; Fujii S
Cancer; 1996 Sep; 78(6):1248-53. PubMed ID: 8826947
[TBL] [Abstract][Full Text] [Related]
18. Expression of cyclin D1 in normal, metaplastic, hyperplastic endometrium and endometrioid carcinoma suggests a role in endometrial carcinogenesis.
Ruhul Quddus M; Latkovich P; Castellani WJ; James Sung C; Steinhoff MM; Briggs RC; Miranda RN
Arch Pathol Lab Med; 2002 Apr; 126(4):459-63. PubMed ID: 11900573
[TBL] [Abstract][Full Text] [Related]
19. Expression of Glut-1 in Normal Endometrium and Endometrial Lesions: Analysis of 336 Cases.
Němejcová K; Rosmusová J; Bártů M; Důra M; Tichá I; Dundr P
Int J Surg Pathol; 2017 Aug; 25(5):389-396. PubMed ID: 28381136
[TBL] [Abstract][Full Text] [Related]
20. Nuclear localization of beta-catenin is correlated with the expression of cyclin D1 in endometrial carcinomas.
Shih HC; Shiozawa T; Miyamoto T; Uchikawa J; Feng Y; Kashima H; Nikaido T; Konishi I
Anticancer Res; 2003; 23(5A):3749-54. PubMed ID: 14666673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
